I agree that this site is using cookies. You can find further informations here.
X
Vitolo, U.
151  results:
Search for persons X
?
1

Pola‐R‐CHP for frontline therapy in DLBCL: Are we saving mo..:

Vitolo, U. ; Frascione, P. M. M. ; Bonello, F.
British Journal of Haematology.  202 (2023)  4 - p. 731-733 , 2023
Link: https://doi.org/10.1111/..
 
?
2

PB2113: FRONTMIND: A PHASE III, RANDOMIZED, DOUBLE-BLIND ST..:

Vitolo, U. ; Nowakowski, G. S. ; Burke, J. M....
HemaSphere.  6 (2022)  - p. 1984-1985 , 2022
Link: https://doi.org/10.1097/..
 
?
3

PB2132: COPANLISIB PLUS RITUXIMAB-BENDAMUSTINE FOR RELAPSED..:

Novo, M. ; Castellino, A. ; Chiappella, A....
HemaSphere.  6 (2022)  - p. 2003-2004 , 2022
Link: https://doi.org/10.1097/..
 
?
4

S221: BORTEZOMIB TO R-DHAP COMPARED TO R-DHAP IN RELAPSED/R..:

Chiappella, A. ; Balzarotti, M. ; Botto, B...
HemaSphere.  6 (2022)  - p. 122-123 , 2022
Link: https://doi.org/10.1097/..
 
?
5

INTENSIFIED (INTRAVENOUS AND INTRATHECAL) CNS PROPHYLAXIS I..:

Conconi, A. ; Chiappella, A. ; Orsucci, L....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
6

COPANLISIB IN COMBINATION WITH RITUXIMAB‐BENDAMUSTINE IN PA..:

Novo, M. ; Castellino, A. ; Chiappella, A....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
7

BASELINE TOTAL METABOLIC TUMOUR VOLUME IS HIGHLY PROGNOSTIC..:

Trněný, M. ; Canales Ruiz, I. ; Martelli, M....
Hematological Oncology.  37 (2019)  S2 - p. 50-52 , 2019
Link: https://doi.org/10.1002/..
 
?
8

First salvage treatment with bendamustine and brentuximab v..:

Broccoli, A. ; Argnani, L. ; Botto, B....
Blood Cancer Journal.  9 (2019)  12 - p. , 2019
Link: https://doi.org/10.1038/..
 
?
9

IBRUTINIB COMPARED TO STANDARD CHEMOTHERAPY FOR CENTRAL NER..:

Rusconi, C. ; Tucker, D. ; Bernard, S....
Hematological Oncology.  37 (2019)  S2 - p. 244-245 , 2019
Link: https://doi.org/10.1002/..
 
?
10

ROBUST: First report of phase III randomized study of lenal..:

Vitolo, U. ; Witzig, T.E. ; Gascoyne, R.D....
Hematological Oncology.  37 (2019)  S2 - p. 36-37 , 2019
Link: https://doi.org/10.1002/..
 
?
11

FIRST SALVAGE TREATMENT WITH BENDAMUSTINE AND BRENTUXIMAB V..:

Stefoni, V. ; Broccoli, A. ; Botto, B....
Hematological Oncology.  37 (2019)  S2 - p. 296-296 , 2019
Link: https://doi.org/10.1002/..
 
?
12

SP-0024 Aggressive Lymphoma (DLBCL) - when does addition of..:

Vitolo, U.
Radiotherapy and Oncology.  133 (2019)  - p. S8 , 2019
Link: https://doi.org/10.1016/..
 
?
13

INTEGRATING TUMOR‐ AND MICROENVIRONMENT‐REFLECTING GENES IN..:

Pileri, S.A. ; Mazzara, S. ; Derenzini, E....
Hematological Oncology.  37 (2019)  S2 - p. 139-140 , 2019
Link: https://doi.org/10.1002/..
 
?
14

Dissection of DLBCL microenvironment provides a gene expres..:

Ciavarella, S. ; Vegliante, M.C. ; Fabbri, M....
Annals of Oncology.  30 (2019)  12 - p. 2015 , 2019
Link: https://doi.org/10.1093/..
 
?
15

MULTI‐OMICS LANDSCAPE OF SPLENIC MARGINAL ZONE LYMPHOMA (SM..:

Bruscaggin, A. ; Mollejo, M. ; Tapia, G....
Hematological Oncology.  37 (2019)  S2 - p. 181-182 , 2019
Link: https://doi.org/10.1002/..
 
1-15